Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere
Edison
Sareum has announced the publication of full Phase I clinical data for lead asset SDC-1801 (a TYK2/JAK1 inhibitor) in the British Journal of Clinical Pharmacology. We view the publication as an extern...
Date:22-Jun-26
Time:9:40 am
Source:RNS
Title:Publication of Phase 1 data on SDC-1801 in BJCP
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE